Citation

83 FR 26487

Canonical document for this Federal Register citation.

Prospective Grant of an Exclusive Patent License: The Development of an Anti-BCMA Immunotoxin for the Treatment of Human Cancer Thursday, June 7, 2018 83 FR 26487